Skip to main content
. 2019 Sep 19;14(9):e0222610. doi: 10.1371/journal.pone.0222610

Table 2. CRT implant characteristics.

Responders
(n = 76)
Non-Responders
(n = 49)
p
Indications for CRT Therapy*, n (%) 0.01
 Class I 39 (51) 16 (33)
 Class IIa 35 (46) 25 (51)
 Class IIb 2 (3) 8 (16)
QRS morphology prior to CRT implantation, n (%)
 Left bundle branch block 53 (70) 22 (45) 0.01
 Right bundle branch block 0 (0) 3 (6) 0.11
 Non-specific interventricular conduction delay 4 (5) 14 (29) <0.01
 Paced 5 (7) 1 (2) 0.47
 Narrow 0 (0) 2 (4) 0.30
 Complete heart block 14 (18) 7 (14) 0.72
CRT type, n (%) 1.00
 CRT-D 54 (71) 34 (69)
 CRT-P 22 (29) 15 (31)
Lead type, n (%) 1.00
 LV lead 72 (95) 47 (96)
 HIS lead 4 (5) 2 (4)
LV lead position, PA chest xray^, n (%) 0.37
 Apical 11 (15) 10 (21)
 Mid 49 (68) 33 (70)
 Basal 12 (17) 4 (9)
LV lead position, lateral chest xray^, n (%) 0.77
 Anterolateral 1 (1) 0 (0)
 Lateral 16 (22) 12 (26)
 Posterolateral 52 (72) 34 (72)
 Posterior 3 (4) 1 (2)

* Indications for CRT therapy per ACC/AHA 2012 Device Guidelines

^ Excludes 6 patients who had HIS leads placed